William Shaw, the Chief Commercial Officer of Ekso Bionics Holdings, Inc. (the “Company”) notified the Board of Directors (the “Board”) of his intention to resign as Chief Commercial Officer of the Company effective March 11, 2022
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
William Shaw resigned as Chief Commercial Officer at EKSO BIONICS HOLDINGS, INC..
Action
resigned
Role
Chief Commercial Officer
Exact text from the filing
William Shaw, the Chief Commercial Officer of Ekso Bionics Holdings, Inc. (the “Company”) notified the Board of Directors (the “Board”) of his intention to resign as Chief Commercial Officer of the Company effective March 11, 2022
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.